Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients

BACKGROUND: Although development of immune checkpoint inhibitors and various molecular target agents has extended overall survival time (OS) in advanced non-small cell lung cancer (NSCLC), a complete cure remains rare. We aimed to identify features and treatment modalities of complete remission (CR)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Aoki, Takuya, Akiba, Takeshi, Nishiyama, Jun, Tajiri, Sakurako, Hayama, Naoki, Takahashi, Genki, Tanaka, Jun, Sato, Masako, Takiguchi, Hiroto, Tomomatsu, Hiromi, Tomomatsu, Katsuyoshi, Takihara, Takahisa, Niimi, Kyoko, Oguma, Tsuyoshi, Kohno, Mitsutomo, Masuda, Ryota, Urano, Tetsuya, Itoh, Hitoshi, Kajiwara, Hiroshi, Nakamura, Naoya, Kunieda, Etsuo, Matsumae, Mitsunori, Iwazaki, Masayuki, Asano, Koichiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873580/
https://ncbi.nlm.nih.gov/pubmed/31752884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1235-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados